Finished

Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA

NCT03054064 · Parker Hannifin Corporation · Updated 7 April 2020

What is being tested: Indego Exoskeleton
For: Cerebrovascular Accident (CVA); Stroke; Hemiplegia
Kind of study: Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join: Ages 18 years and older. About 48 people. The full rules are on the registry page.
Where: United States (7 sites)
When: Starts or started 21 Feb 2017, ends 17 Jan 2018. Registered 15 Feb 2017.
Results: Posted on the registry on 7 April 2020.

In the researchers' words

The purpose of this study is to evaluate the safety and effectiveness of the Indego exoskeleton as a gait training tool for individuals with hemiplegia due to Cerebrovascular Accident (CVA).

ClinicalTrials.gov, NCT03054064

Sites

Cedars-Sinai Health SystemLos Angeles, California, United States
Shepherd CenterAtlanta, Georgia, United States
Rehabilitation Institute of Chicago (Shirley Ryan AbilityLab)Chicago, Illinois, United States
Kessler FoundationWest Orange, New Jersey, United States
St. Charles HospitalPort Jefferson, New York, United States
TIRR Memorial HermannHouston, Texas, United States
Sheltering Arms Physical Rehabilitation CentersMechanicsville, Virginia, United States